Go Pro
→ The world’s least risky AI stock? (From Stansberry Research) (Ad)tc pixel Free AVAH Stock Alerts

Aveanna Healthcare (AVAH) Competitors

Aveanna Healthcare logo
$11.62 +0.33 (+2.92%)
As of 09:41 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

AVAH vs. HIMS, CHE, BLLN, HNGE, and RDNT

Should you buy Aveanna Healthcare stock or one of its competitors? Aveanna Healthcare's main competitors and comparable companies include Hims & Hers Health (HIMS), Chemed (CHE), Billiontoone (BLLN), Hinge Health (HNGE), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Aveanna Healthcare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Aveanna Healthcare (NASDAQ:AVAH) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Aveanna Healthcare has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.84$128.37M-$0.63N/A
Aveanna Healthcare$2.43B1.04$225.03M$1.189.85

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 37 more articles in the media than Aveanna Healthcare. MarketBeat recorded 57 mentions for Hims & Hers Health and 20 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.60 beat Hims & Hers Health's score of 0.00 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
10 Very Positive mention(s)
5 Positive mention(s)
22 Neutral mention(s)
12 Negative mention(s)
2 Very Negative mention(s)
Neutral
Aveanna Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health currently has a consensus price target of $32.43, suggesting a potential upside of 12.44%. Aveanna Healthcare has a consensus price target of $11.22, suggesting a potential downside of 3.42%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Hims & Hers Health has a beta of 2.4, suggesting that its share price is 140% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

Aveanna Healthcare has a net margin of 10.37% compared to Hims & Hers Health's net margin of -5.51%. Aveanna Healthcare's return on equity of 124.68% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-5.51% -5.89% -1.39%
Aveanna Healthcare 10.37%124.68%7.07%

Summary

Aveanna Healthcare beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Chemed?

Aveanna Healthcare (NASDAQ:AVAH) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Chemed has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.04$225.03M$1.189.85
Chemed$2.53B2.78$265.24M$19.9127.08

Aveanna Healthcare has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Chemed has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market.

Aveanna Healthcare presently has a consensus price target of $11.22, indicating a potential downside of 3.42%. Chemed has a consensus price target of $530.75, indicating a potential downside of 1.55%. Given Chemed's higher possible upside, analysts clearly believe Chemed is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
Chemed
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17

In the previous week, Aveanna Healthcare had 18 more articles in the media than Chemed. MarketBeat recorded 20 mentions for Aveanna Healthcare and 2 mentions for Chemed. Chemed's average media sentiment score of 1.73 beat Aveanna Healthcare's score of 0.60 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Chemed has a net margin of 10.60% compared to Aveanna Healthcare's net margin of 10.37%. Aveanna Healthcare's return on equity of 124.68% beat Chemed's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
Chemed 10.60%31.77%18.90%

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Chemed beats Aveanna Healthcare on 10 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Billiontoone?

Aveanna Healthcare (NASDAQ:AVAH) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Aveanna Healthcare has higher revenue and earnings than Billiontoone. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.04$225.03M$1.189.85
Billiontoone$397.41M10.91$7.45M$0.70134.72

88.0% of Aveanna Healthcare shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 50.2% of Billiontoone shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Aveanna Healthcare and Aveanna Healthcare both had 20 articles in the media. Aveanna Healthcare's average media sentiment score of 0.60 beat Billiontoone's score of 0.50 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
8 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare presently has a consensus price target of $11.22, indicating a potential downside of 3.42%. Billiontoone has a consensus price target of $126.71, indicating a potential upside of 34.37%. Given Billiontoone's higher probable upside, analysts clearly believe Billiontoone is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Aveanna Healthcare has a net margin of 10.37% compared to Billiontoone's net margin of 8.04%. Aveanna Healthcare's return on equity of 124.68% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
Billiontoone 8.04%9.96%5.35%

Summary

Aveanna Healthcare beats Billiontoone on 10 of the 14 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Aveanna Healthcare (NASDAQ:AVAH) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

In the previous week, Aveanna Healthcare had 9 more articles in the media than Hinge Health. MarketBeat recorded 20 mentions for Aveanna Healthcare and 11 mentions for Hinge Health. Aveanna Healthcare's average media sentiment score of 0.60 beat Hinge Health's score of 0.43 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aveanna Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare has higher revenue and earnings than Hinge Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M11.50-$528.26M$1.2868.24
Aveanna Healthcare$2.43B1.04$225.03M$1.189.85

Hinge Health has a net margin of 15.15% compared to Aveanna Healthcare's net margin of 10.37%. Aveanna Healthcare's return on equity of 124.68% beat Hinge Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 65.44% 14.54%
Aveanna Healthcare 10.37%124.68%7.07%

88.0% of Aveanna Healthcare shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hinge Health has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

Hinge Health presently has a consensus target price of $100.57, indicating a potential upside of 15.14%. Aveanna Healthcare has a consensus target price of $11.22, indicating a potential downside of 3.42%. Given Hinge Health's stronger consensus rating and higher possible upside, research analysts clearly believe Hinge Health is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Hinge Health beats Aveanna Healthcare on 9 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to RadNet?

Aveanna Healthcare (NASDAQ:AVAH) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aveanna Healthcare currently has a consensus target price of $11.22, indicating a potential downside of 3.42%. RadNet has a consensus target price of $88.00, indicating a potential upside of 14.50%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
RadNet
2 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.78

Aveanna Healthcare has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market.

In the previous week, RadNet had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 23 mentions for RadNet and 20 mentions for Aveanna Healthcare. RadNet's average media sentiment score of 0.92 beat Aveanna Healthcare's score of 0.60 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
9 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.04$225.03M$1.189.85
RadNet$2.04B2.96-$18.65M-$0.27N/A

Aveanna Healthcare has a net margin of 10.37% compared to RadNet's net margin of -0.93%. Aveanna Healthcare's return on equity of 124.68% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
RadNet -0.93%2.64%0.94%

Summary

Aveanna Healthcare beats RadNet on 11 of the 17 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVAH vs. The Competition

Export
MetricAveanna HealthcareHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.54B$9.89B$7.07B$13.00B
Dividend YieldN/A2.55%2.58%10.72%
P/E Ratio9.8735.31269.6325.21
Price / Sales1.044.83596.7099.90
Price / Cash13.12124.0070.5350.75
Price / Book12.495.3213.116.24
Net Income$225.03M$309.96M$3.45B$347.70M
7 Day Performance22.44%0.26%0.77%0.87%
1 Month Performance24.41%0.67%1.44%0.90%
1 Year Performance61.39%19.92%67.07%20.13%

Aveanna Healthcare Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVAH
Aveanna Healthcare
4.1737 of 5 stars		$11.62
+2.9%		$11.22
-3.4%		+57.9%$2.54B$2.43B9.8735,500
HIMS
Hims & Hers Health
2.4387 of 5 stars		$32.08
+4.1%		$31.43
-2.0%		-40.4%$7.43B$2.35BN/A2,442
CHE
Chemed
4.2769 of 5 stars		$539.13
-0.3%		$530.75
-1.6%		+19.0%$7.15B$2.53B27.0815,811
BLLN
Billiontoone
4.4876 of 5 stars		$142.52
+3.8%		$126.00
-11.6%		N/A$6.55B$305.11M259.13620
HNGE
Hinge Health
3.5894 of 5 stars		$79.90
+2.9%		$86.07
+7.7%		+50.1%$6.18B$587.86MN/A1,437

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...
Decentralized Masters | Sponsoredtc pixel
American retirees will miss THIS. Big Banks just moved in.
Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...
Cedar Gold Group | Sponsoredtc pixel
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...
Golden Crest Metals | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel